We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: JPMorgan, Home Depot, Merck, T-Mobile US and Twilio
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 10, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , The Home Depot, Inc. (HD - Free Report) , Merck & Co., Inc. (MRK - Free Report) , T-Mobile US, Inc. (TMUS - Free Report) and Twilio Inc. (TWLO - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for JPMorgan, Home Depot and Merck
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase, The Home Depot, and Merck. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of JPMorgan have been standout performers lately, with the stock up +72.4% over the past year vs. +45.7% for the S&P 500 index. The Zacks analyst believes that branch openings in new regions, inorganic expansion efforts and a strong mortgage banking business are likely to keep supporting financials.
While the Fed's accommodative policy and near-zero rates are expected to hurt interest income and margins, gradual economic recovery will likely lead to a rise in demand for loans. Further, JPMorgan's impressive capital deployments reflect earnings strength and solid balance sheet.
The Home Depot shares have gained +24.9% over the last six months against the Zacks Retail Building Products industry's gain of +24.2%. The Zacks analyst believes that the company's interconnected retail strategy and underlying technology infrastructure have helped boost web traffic in fiscal 2020.
Meanwhile, broad-based strength across its businesses and geographies led to comparable sales growth in fourth-quarter fiscal 2020. The company also gained from strong growth in its Pro and DIY customer categories. However, it has been witnessing soft margins trend due to higher expenses. Also, negative product mix and pressures from higher transportation costs have been major headwinds.
Shares of Merck have gained +4.2% in the past three months against the Zacks Large Cap Pharmaceuticals industry's gain of +3.3%. The Zacks analyst believes that Merck's drugs like Keytruda, Lynparza and Bridion have been boosting sales. Keytruda sales have benefited from increasing usage in cancer immunotherapy.
Meanwhile, animal health and vaccine products remain core growth drivers. However, generic competition for several drugs and rising competitive pressure will continue to remain overhangs on the top line. Further, reduced wellness visits amid the pandemic have weighed on the sales of Merck's physician-administered drugs and vaccines.
Other noteworthy reports we are featuring today include T-Mobile US and Twilio.
+1,500% Growth: One of 2021's Most Exciting Investment Opportunities
In addition to the stocks you read about above, would you like to see Zacks' top picks to capitalize on the Internet of Things (IoT)? It is one of the fastest-growing technologies in history, with an estimated 77 billion devices to be connected by 2025. That works out to 127 new devices per second.
Zacks has released a special report to help you capitalize on the Internet of Things's exponential growth. It reveals 4 under-the-radar stocks that could be some of the most profitable holdings in your portfolio in 2021 and beyond.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: JPMorgan, Home Depot, Merck, T-Mobile US and Twilio
For Immediate Release
Chicago, IL – May 10, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , The Home Depot, Inc. (HD - Free Report) , Merck & Co., Inc. (MRK - Free Report) , T-Mobile US, Inc. (TMUS - Free Report) and Twilio Inc. (TWLO - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for JPMorgan, Home Depot and Merck
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase, The Home Depot, and Merck. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of JPMorgan have been standout performers lately, with the stock up +72.4% over the past year vs. +45.7% for the S&P 500 index. The Zacks analyst believes that branch openings in new regions, inorganic expansion efforts and a strong mortgage banking business are likely to keep supporting financials.
While the Fed's accommodative policy and near-zero rates are expected to hurt interest income and margins, gradual economic recovery will likely lead to a rise in demand for loans. Further, JPMorgan's impressive capital deployments reflect earnings strength and solid balance sheet.
(You can read the full research report on JPMorgan here >>>)
The Home Depot shares have gained +24.9% over the last six months against the Zacks Retail Building Products industry's gain of +24.2%. The Zacks analyst believes that the company's interconnected retail strategy and underlying technology infrastructure have helped boost web traffic in fiscal 2020.
Meanwhile, broad-based strength across its businesses and geographies led to comparable sales growth in fourth-quarter fiscal 2020. The company also gained from strong growth in its Pro and DIY customer categories. However, it has been witnessing soft margins trend due to higher expenses. Also, negative product mix and pressures from higher transportation costs have been major headwinds.
(You can read the full research report on The Home Depot here >>>)
Shares of Merck have gained +4.2% in the past three months against the Zacks Large Cap Pharmaceuticals industry's gain of +3.3%. The Zacks analyst believes that Merck's drugs like Keytruda, Lynparza and Bridion have been boosting sales. Keytruda sales have benefited from increasing usage in cancer immunotherapy.
Meanwhile, animal health and vaccine products remain core growth drivers. However, generic competition for several drugs and rising competitive pressure will continue to remain overhangs on the top line. Further, reduced wellness visits amid the pandemic have weighed on the sales of Merck's physician-administered drugs and vaccines.
(You can read the full research report on Merck here >>>)
Other noteworthy reports we are featuring today include T-Mobile US and Twilio.
+1,500% Growth: One of 2021's Most Exciting Investment Opportunities
In addition to the stocks you read about above, would you like to see Zacks' top picks to capitalize on the Internet of Things (IoT)? It is one of the fastest-growing technologies in history, with an estimated 77 billion devices to be connected by 2025. That works out to 127 new devices per second.
Zacks has released a special report to help you capitalize on the Internet of Things's exponential growth. It reveals 4 under-the-radar stocks that could be some of the most profitable holdings in your portfolio in 2021 and beyond.
Click here to download this report FREE >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.